Expanding the conversation on high-throughput virome sequencing standards to include consideration of microbial contamination sources.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.Acta neuropathologica communications · 2016
   Article
2. Reply to "Expanding the conversation on high-throughput virome sequencing standards to include consideration of microbial contamination sources".mBio · 2014
   Article

Corrections and comments

• Commented on by
  Reply to "Expanding the conversation on high-throughput virome sequencing standards to include consideration of microbial contamination sources".2014
• Comment on
  Standards for sequencing viral genomes in the era of high-throughput sequencing.2014

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as